Skip to main content

Canada's opioid epidemic shows no signs of abating, and a sense of urgency is clearly gripping law enforcement.

In recent months, police have begun laying manslaughter charges against drug dealers for allegedly selling fatal doses of fentanyl and other dangerous synthetic opiates.

It's happened in Alberta and Ontario, and is forecast to become more common. The prosecutions are a signal that Crown attorneys and police see the need to act purposefully in the face of a crisis that will cost more than 3,000 lives this year.

Story continues below advertisement

But while the impulse is understandable, it doesn't equate to being the best response.

Stiff trafficking penalties already exist and clearly aren't working – an outcome supported by research. One summary of the findings by experts at the University of Toronto in 2014 concluded that "crime is not deterred, generally, by harsher sentences."

In contrast, harm-reduction strategies such as legalization, opiate substitution (or prescription) and supervised injection have proven their effectiveness in places like Portugal and Switzerland.

British Columbia, ground zero for Canada's opiate explosion, takes a similar approach. It notably does not routinely pursue manslaughter charges.

Then there's the murky notion of assigning criminal responsibility. A 1993 Supreme Court ruling established a test: "objective foreseeability of the risk of bodily harm which is neither trivial nor transitory, in the context of a dangerous act."

That case upheld a conviction for directly administering a fatal cocaine injection with the deceased's consent. How far might the concept stretch?

In Ontario, apparently to providing fentanyl to someone who knowingly and specifically sought it out, and later died.

Story continues below advertisement

The decision to illegally purchase and then ingest a dangerous drug is an individual one, but the logic here seems to be that the sellers know fentanyl can kill and are thus also responsible.

Why stop there? Why not apply it to manufacturers or importers of fentanyl's precursor chemicals? How about doctors who were cavalier with their prescription pads and contributed to the country's opioid crisis?

A criminal crackdown might appeal to some, but it is a distraction. The only option with a real chance of saving lives is for Ottawa and the provinces to treat the crisis as a public-health matter, and focus all their best resources on harm reduction.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter